Patent · US Expired

Compounds for therapy and diagnosis of lung cancer and methods for their use

US6444425B1 · kind B1 · utility

62Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 1999
Grant dateSep 3, 2002
Priority date
Expiry dateAug 9, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for the therapy and diagnosis of cancer, such as lung cancer, are disclosed. Compositions may comprise one or more lung tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a lung tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as lung cancer. Diagnostic methods based on detecting a lung tumor protein, or mRNA encoding such a protein, in a sample are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.